Mid-day market update: FuelCell Energy jumps after Q3 results, RedHill Biopharma shares slide


Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,223,890 cases with around 662,260 deaths. India confirmed a total of at least 33,289,570 cases and 443,210 deaths, while Brazil reported over 21,006,420 COVID-19 cases with 587,060 deaths. In total, there were at least 225,389,500 cases of COVID-19 worldwide with more than 4,642,050 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Health care shares gained 0.4% on Tuesday. Meanwhile, top gainers in the sector included BELLUS Health Inc. BLU +undefined% (Get Free Alerts for BLU), up 26% and aTyr Pharma, Inc. LIFE +undefined% (Get Free Alerts for LIFE) up 25%.

In trading on Tuesday, financials shares fell by 1.1%.

Top Headline

The annual inflation rate eased to 5.3% in August compared to a 13-year high level of 5.4% in June. The monthly rate eased to 0.3% versus 0.5% a month ago.

Equities Trading UP

aTyr Pharma, Inc. LIFE +undefined% (Get Free Alerts for LIFE) shares shot up 25% to $11.48 after multiple firms maintained bullish ratings on the stock and raised their respective price targets. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.

Shares of FuelCell Energy, Inc. FCEL +undefined% got a boost, shooting 22% to $6.83 after the company reported better-than-expected Q3 results.

BELLUS Health Inc. BLU +undefined% (Get Free Alerts for BLU) shares were also up, gaining 26% to $6.03. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic cough. HC Wainwright on Tuesday raised its price target on the stock.

Equities Trading DOWN

Virpax Pharmaceuticals, Inc. VRPX +36.51% shares tumbled 37% to $6.15 after the company priced a 6.67 million share common stock offering at $6 per share.

Shares of RedHill Biopharma Ltd. RDHL +32.25% were down 32% to $4.99 after the company announced preliminary top-line data from the Phase 2/3 study with opaganib showed that the study did not meet its primary endpoint.

Herbalife Nutrition Ltd. HLF +20.02% was down, falling 16% to $45.65 after the company revised its guidance for the third quarter and full year 2021. The company said it sees Q3 adjusted earnings of $1.00 to $1.20 per share. Herbalife updated its full year adjusted earnings guidance to a range of $4.55 to $4.95 per share, while adjusted EBITDA is being lowered to a range of $860 million to $910 million.

Commodities

In commodity news, oil traded up 0.3% to $70.69, while gold traded up 0.7% to $1,806.90.

Silver traded up 0.2% Tuesday to $23.85 while copper fell 1% to $4.3255.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.17%, the Spanish Ibex Index fell 0.66% and the German DAX 30 gained 0.01%. Meanwhile, the London’s FTSE 100 dropped 0.62%, French CAC 40 fell 0.61% and Italy’s FTSE MIB gained 0.08%.

Spanish consumer prices increased 3.3% year-over-year in August following a 2.9% increase in the previous month. The UK unemployment rate dropped to 4.6% in the three months to July.

Economics

The NFIB small business optimism index rose to 100.1 points in August from 99.7 points in the previous month.

The annual inflation rate eased to 5.3% in August compared to a 13-year high level of 5.4% in June. The monthly rate eased to 0.3% versus 0.5% a month ago.

Benzinga does not provide investment advice. All rights reserved.

Feed news

Latest Forex Analysis


Latest Forex Analysis

Editors’ Picks

EUR/USD remains pressured after US data misses estimates

EUR/USD is trading closer to 1.1750, paring its recovery from earlier in the day as the safe-haven dollar is bid. US Consumer Sentiment missed estimates with 72 points in September. The financial woes of China's Evergrande are weighing on sentiment.

EUR/USD News

GBP/USD trades under 1.38 amid on UK data, dollar strength

GBP/USD is on the back foot, trading under 1.38 after UK Retail Sales figures disappointed with -0.9% in August, worse than expected. Brexit uncertainty and dollar demand weighed on the pair earlier. 

GBP/USD News

XAU/USD surrenders intraday gains, drops closer to $1,750 level

Gold struggled to preserve its intraday gains and dropped to the lower end of the daily trading range during the early North American session. 

Gold News

Experts say Ripple will win SEC lawsuit, which might propel XRP to new all-time highs

The latest development in the ongoing SEC vs. Ripple lawsuit is that documents are classified as privileged and blocked for public viewing. Though institutional investors are yet to take big bets on the altcoin in 2021, retail investors are actively trading in XRP.

Read more

US Michigan Consumer Sentiment Preview: Markets will have to look hard for positive signs

Consumer outlook expected to rebound to 72.2 in September. August’s 70.2 was the lowest since December 2011. Inflation and Delta variant wearing on US optimism. Markets face negative dollar risk from fading consumer optimism.

Read more

Majors

Cryptocurrencies

Signatures